Sorrento Therapeutics Inc (SRNE): 4 highlights from this morning. * SP102...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Wednesday, 09/29/2021 12:24:38 PM

Wednesday, September 29, 2021 12:24:38 PM

4 highlights from this morning.
* SP102 news is outstanding. Marketing as early as mid 2022. Sales potential $10 Billion.
* STIX and COVIDROPS are progressing rapidly...Mexico, Brazil, Canada, UK and US states need the tests and antibodies! Huge sales potential in coming months.
* Two new second generation vaccines to head off new variants and provide more effective longer lasting booster shots!
* Dozens of best in class cancer drugs. Abivertinib leading the way!

Henry still aiming for $200-400 Billion market Cap in 3-5 years...and I trust him!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM